Q3 2024 Earnings Call Transcript November 14, 2024 TriSalus Life Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.4 EPS, expectations were $-0.36. Operator: Good morning, and ...
Detailed price information for Shuttle Pharmaceuticals Holdings Inc (SHPH-Q) from The Globe and Mail including charting and trades.
Researchers develop a plug-and-play test that enables real-time monitoring of engineered T-cells, improving the precision and ...
A novel test enables real-time monitoring of T cells that have been engineered to fight cancer, after re-introduction into the body of a cancer patient. This simple and innovative test provides ...
A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a new study.
Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate ...
The miniature models have the potential to significantly speed up vaccine development, advance cancer treatment research, and enhance health outcomes for a wide range of diseases. To gain deeper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback